Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MREO

Mereo BioPharma (MREO)

Mereo BioPharma Group PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MREO
DateTimeSourceHeadlineSymbolCompany
03/04/202422:30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:MREOMereo BioPharma Group PLC
28/03/202407:01GlobeNewswire Inc.Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MREOMereo BioPharma Group PLC
05/03/202423:30GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma ConferenceNASDAQ:MREOMereo BioPharma Group PLC
10/02/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
10/02/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
10/02/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
10/02/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
07/02/202408:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
27/01/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
27/01/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
24/01/202408:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MREOMereo BioPharma Group PLC
08/01/202423:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MREOMereo BioPharma Group PLC
08/01/202423:00GlobeNewswire Inc.Mereo BioPharma Provides Update on Pipeline Progress and Corporate DevelopmentsNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
03/01/202408:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
19/12/202308:16Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:MREOMereo BioPharma Group PLC
19/12/202308:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
30/11/202308:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
16/11/202323:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
24/10/202307:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
24/10/202307:01GlobeNewswire Inc.Mereo BioPharma Reports on Recent Program Developments and Provides Financial UpdateNASDAQ:MREOMereo BioPharma Group PLC
17/10/202322:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MREOMereo BioPharma Group PLC
15/10/202307:30GlobeNewswire Inc.Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)NASDAQ:MREOMereo BioPharma Group PLC
09/10/202323:00GlobeNewswire Inc.Ultragenyx to Present Setrusumab (UX143) Update at ASBMR 2023 Including New Data from Phase 2/3 Orbit Study in Osteogenesis Imperfecta (OI)NASDAQ:MREOMereo BioPharma Group PLC
21/09/202321:00GlobeNewswire Inc.Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare ConferenceNASDAQ:MREOMereo BioPharma Group PLC
 Showing the most relevant articles for your search:NASDAQ:MREO